Antisense Therapeutics Limited (ANP) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly. ANP has three products including ATL1102 injection for Multiple Sclerosis, ATL1103 injection for growth & sight disorders, and ATL1102 inhaled for asthma.
Antisense Therapeutics Limited operators in Health Care sector and under industry of Pharmaceuticals. The company website is: http://www.antisense.com.au.
You can also check out dividend history for similar stocks in the same sector as follows:
ANP Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found